Abstract
Effects of 5mg and 10mg Dalfampridine Extended Release Tablets on 6-Minute Walk Distance in People with Multiple Sclerosis: A Subgroup Analysis of a Double-Blind, Placebo-Controlled Trial (S01.007)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have